SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 184,445 Value ($000) $1,682 Avg Close — Range —
Q1 2025
Shares 172,023 Value ($000) $1,368 Avg Close — Range —
Q4 2024
Shares 169,015 Value ($000) $918 Avg Close — Range —
Q3 2024
Shares 136,422 Value ($000) $985 Avg Close — Range —
Q2 2024
Shares 137,602 Value ($000) $1,494 Avg Close — Range —
Q1 2024
Shares 140,449 Value ($000) $2,632 Avg Close — Range —
Q4 2023
Shares 132,500 Value ($000) $2,871 Avg Close — Range —
Q3 2023
Shares 145,300 Value ($000) $2,990 Avg Close — Range —
Q2 2023
Shares 139,105 Value ($000) $6,541 Avg Close — Range —
Q1 2023
Shares 137,097 Value ($000) $5,753 Avg Close — Range —
Q4 2022
Shares 134,666 Value ($000) $5,136 Avg Close — Range —
Q3 2022
Shares 136,857 Value ($000) $5,359 Avg Close — Range —
Q2 2022
Shares 140,202 Value ($000) $4,529 Avg Close — Range —
Q2 2021
Shares 11,146 Value ($000) $633 Avg Close — Range —
Q4 2019
Shares 59,047 Value ($000) $4,263 Avg Close — Range —
Q1 2019
Shares 1,830 Value ($000) $291 Avg Close — Range —
Q3 2018
Shares 1,963 Value ($000) $277 Avg Close — Range —
Q1 2018
Shares 1,606 Value ($000) $259 Avg Close — Range —